Kenway Pharmaceutical Limited

Kenway Pharmaceutical Limited is a legitimate Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622) on 2007-07-06 (operating for 19 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full civil rights (Statutory verification: September 2026).

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [38138580] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [1147413] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To inspect certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier beneficial ownership (UBO), formal certified registers must be retrieved through statutory registry inspection or corporate due diligence procedures.

Yes. Statutory indexing confirms that Kenway Pharmaceutical Limited has accumulated 20 official filing dossier(s) archived in the Hong Kong Companies Registry. Pursuant to Section 107 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days of each incorporation anniversary. Available stamped dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic official barcode verification.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Department of Health - Authorized Poison Seller (Licence No. 25/4A/2007); 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with Hong Kong judicial writs database; no public court cases or compulsory winding-up petitions (HCCW) were found for this entity.

The statutory registered office (corporate headquarters on official record) of Kenway Pharmaceutical Limited is situated at: [ROOM 7, G/F, 442-456 KING'S ROAD, NORTH POINT, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622) of Hong Kong, all companies registered in Hong Kong must maintain an official registered office within the Hong Kong SAR where official communications, regulatory notices, and legal court process may be lawfully served.

Under the Companies Ordinance (Cap. 622) and Business Registration Ordinance (Cap. 310) of Hong Kong, incorporated private corporations are not legally required to register an official website domain with the government. An entity's legal personality and authorized status are confirmed strictly through official statutory filings—such as the Certificate of Incorporation (CI), latest Annual Return (Form NAR1), and the Business Registration Certificate issued by the Inland Revenue Department (BRN: 38138580). International trade partners are advised to verify statutory registry records rather than relying solely on self-published promotional websites.